This patent teaches how to generate a myocardial graft using embryonic stem cells that have been induced to differentiate into the cardiac lineage. This patent is especially useful for post myocardial infarction in which scar tissue replaces functional myocardium resulting in decreased cardiac output. Numerous methods have been previously described for generation of myocardial cells from embryonic and non-embryonic sources that are capable of engrafting in injured myocardium.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.